# Blue Note Therapeutics, Inc. — Form D

Blue Note Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-12. The offering totals $30.0M, of which $13.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2021-02-12
- Form: D
- Accession: 0001777911-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $13.0M
- Remaining: $17.0M
- Investors: 2
- Date of first sale: 2021-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389303

## Issuer

- Name: Blue Note Therapeutics, Inc.
- CIK: 0001777911
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 548 MARKET ST., #55709, SAN FRANCISCO, CA, 94104
- Phone: 408-669-2789

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Firlik | Director | Rowayton, CT |
| John Harris | Director | Richardson, TX |
| Geoffrey Eich | Director | SAN FRANCISCO, CA |
| Geoffrey Eich | Executive Officer | SAN FRANCISCO, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-08-24](https://search.stillhousedata.com/formd/0001168404-21-000011) | D/A | $50.0M | $15.5M |

## More

- [CIK 1777911 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1777911&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001777911-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.